Test Code LAB683 Ethosuximide, Serum
Additional Codes
Sunquest order code: ETHSXM
MAYO code: ETX
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Serum gel tubes should be centrifuged within 2 hours of collection.
2. Red-top tubes should be centrifuged and the serum aliquoted into a plastic vial within 2 hours of collection.
Secondary ID
8769Useful For
Monitoring ethosuximide therapy
Determining compliance
Assessing ethosuximide toxicity
Method Name
Enzyme-Multiplied Immunoassay Technique (EMIT)
Reporting Name
Ethosuximide, SSpecimen Type
SerumSpecimen Minimum Volume
0.25 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 14 days | |
Frozen | 28 days | ||
Ambient | 14 days |
Reject Due To
Gross hemolysis | Reject |
Reference Values
Therapeutic: 40-100 mcg/mL
Critical value: >150 mcg/mL
Method Description
The enzyme-multiplied immunoassay technique assay is a homogeneous enzyme immunoassay technique used for the analysis of specific compounds in biological fluids. The assay is based on competition between drug in the sample and drug labeled with the enzyme glucose-6-phosphate dehydrogenase (G6PD) for antibody binding sites. Enzyme activity decreases upon binding to the antibody, so the drug concentration in the sample can be measured in terms of enzyme activity. Active enzyme converts oxidized nicotinamide adenine dinucleotide (NAD) to NADH, resulting in an absorbance change that is measured spectrophotometrically. Endogenous serum G6PD does not interfere, because the coenzyme functions only with the bacterial (Leuconostoc mesenteroides) enzyme employed in the assay.(Package insert: Ethosuximide reagent. Siemens Healthcare Diagnostics, Inc; 04/2015)
Day(s) Performed
Monday through Saturday
Report Available
Same day/1 dayPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
80168
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ETX | Ethosuximide, S | 3616-0 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
8769 | Ethosuximide, S | 3616-0 |
Forms
If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
-Therapeutics Test Request (T831)